DSpace at RU >

Search Results

Results 1-14 of 14.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	Sacuman	Berends, M.A.M.; Andriessen, M.P.
	2009	Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: a pilot study.	Lingen, R.G. van; Jong, E.M.G.J. de; Berends, M.A.M.; Seijger, M.M.B.; Erp, P.E.J. van; Kerkhof, P.C.M. van de
	2008	Optimization of antipsoriatic treatments with special reference to monitoring of methotrexate-induced liver toxicity	Berends, M.A.M.
	2008	Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: A pilot study	Lingen, R.G. van; Jong, E.M.G.J. de; Berends, M.A.M.; Seyger, M.M.B.; Erp, P.E.J. van; Kerkhof, P.C.M. van de
	2008	Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome.	Driessen, R.J.B.; Berends, M.A.M.; Boezeman, J.B.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2008	Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies.	Lingen, R.G. van; Korver, J.E.M.; Kerkhof, P.C.M. van de; Berends, M.A.M.; Rens, D.W.A. van; Langewouters, A.M.G.; Boezeman, J.B.M.; Seyger, M.M.B.; Jong, E.M.G.J. de
	2007	Methotrexaat : hepatotoxiciteit en het leverbiopt	Berends, M.A.M.; Kerkhof, P.C.M. van de; Oijen, M.G.H. van; Drenth, J.P.H.; Jong, E.M.G.J. de
	2007	Biologicals in de praktijk : prospectieve cohortmonitoring van high need psoriasispatiënten	Driessen, R.J.B.; Berends, M.A.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2007	Dermatologists' adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey.	Berends, M.A.M.; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de; Gerritsen, M.J.P.
	2007	Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice.	Berends, M.A.M.; Driessen, R.J.B.; Langewouters, A.M.G.; Boezeman, J.B.M.; Kerkhof, P.C.M. van de; Jong, E.M.G.J. de
	2007	Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.	Berends, M.A.M.; Oijen, M.G.H. van; Snoek, J.; Kerkhof, P.C.M. van de; Drenth, J.P.H.; Krieken, J.H.J.M. van; Jong, E.M.G.J. de
	2007	Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.	Berends, M.A.M.; Snoek, J.; Jong, E.M.G.J. de; Krieken, J.H.J.M. van; Knegt, R.J. de; Oijen, M.G.H. van; Kerkhof, P.C.M. van de; Drenth, J.P.H.
	2006	Methotrexaatbehandeling bij ernstige chronische plaque psoriasis.	Berends, M.A.M.; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de
	2006	Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.	Berends, M.A.M.; Snoek, J.; Jong, E.M.G.J. de; Kerkhof, P.C.M. van de; Oijen, M.G.H. van; Krieken, J.H.J.M. van; Drenth, J.P.H.

1